ABOUT BIORASI
Biorasi is a customer-focused, full-service, contract research organization (CRO) that delivers fast and flexible solutions across global clinical trials to maximize speed-to-market for its sponsors. As the leader in neurology, nephrology, dermatology, and the rare and urgent disease market, Biorasi sets new benchmarks for speed, agility, and quality in patient enrollment, decentralized trials, and data transparency.
FEATURED PRODUCTS/SERVICES
The biggest issues for faltering trials? Incomplete planning and enrollment issues can explode into big problems if not addressed early enough. Biorasi offers a no-commitment, no-charge, fast consulting assessment that will identify and correct these issues in your study early – before they grow too big to manage.
BLOGS
-
![Asia iStock-1190455899]( "Bridging The Gap: Breaking APAC Into The US FDA Market")
For APAC companies, it's important to identify the differences in care standards, formulate strategies for compliance, and develop solutions to bridge the regulatory gap and realize FDA approval.
-
![GettyImages-1296723604 CRO turnover training]( "Top Tips For Taming CRO Turnover")
Employee turnover, even during complex clinical trials, should never be the breaking point of a project. Avoid these instances and keep studies on track by developing proactive employee retention strategies.
-
![GettyImages-667825028 cancer]( "The Past, Present, And Future Of Treating Hematological Cancers")
What was once science fiction has moved up to second-line therapy. Read this author's take on navigating the trajectory of how CAR T-Cell Therapy will be used for diffuse large B-cell lymphoma.
-
![GettyImages-1392267102 IV therapy]( "Four Milestones On The Path To Neurological Cell Therapy")
How did we arrive at neurological cell therapy solutions? Dr. Ole Isacson explores the stem cell steppingstones – from blood transfusions to Parkinson’s Disease treatments.
-
![Recruitment]( "Seven Tips For Hiring And Retaining Top CRO Talent")
Which steps are needed to hire the best and brightest at CROs? Get a better understanding of the challenges facing today’s recruiters and explore these seven tips for hiring and retaining top CRO talent.
-
![doc-patient]( "Best Care Scenario: Nephrology Patient Safety Starts In The Clinical Trial Setting")
Is the clinical trial setting the best environment to ensure a patient’s safety? Dr. Jamie P. Dwyer discusses how nephrology clinical trials identify future patient risk factors for medication and treatment in the real-world setting.
CONTACT INFORMATION
Biorasi
18851 NE 29th Ave. Suite 800
Miami, FL 33180
UNITED STATES
Phone: +1 786-396-1273
Contact: Aimee Fernandes
WHITE PAPERS & CASE STUDIES
-
![Diversity-GettyImages-1450298872]( "Patient Diversity: Identifying Challenges, Opportunities, And Best Practices")
By listening to the voice of patient diversity and implementing FDA guidance measures, learn how stakeholders can improve trust, engagement, data reliability, patient outcomes, and promote public health.
-
![India-GettyImages-157314794]( "Consider India For Your Next HCC International Trial")
Assess the feasibility of India as a potential venue for HCC trials as well as its epidemiology, historical perceptions, and untapped potential for international clinical research opportunities.
-
![Kidneys]( "Elevated Risk: Exploring The Links Between Chronic Kidney Disease And Cardiovascular Disease")
Chronic kidney disease has become inextricably linked with cardiovascular conditions, a discovery that has yielded synergistic diagnosis and intervention methods. Dr. Jamie Dwyer explores the connection between these two diseases, which has brought about a sort of renaissance for nephrology research.
-
![iStock-1197955140 PS]( "No Shortcuts: Two Pathways To Building A Future For Huntington’s Disease Research")
One of the tenets of clinical research is that findings often result in more questions than answers. For Huntington’s disease, the journey toward understanding and treatment continues to be a methodical one. Dr. Ole Isacson highlights two pathways to ongoing research for this rare disease.
-
![Diversity.jpg]( "The Missing Minority: Understanding The Three Main Barriers To Diversity In Today’s Clinical Trials")
While there are socioeconomic factors contributing to the reasons behind the lack of diversity, the exclusion of minority populations in clinical trials can be a scientifically flawed misstep. By focusing on a single demographic, clinical research findings become limited, and by ignoring other representative populations, "unexpected" side effects may be more commonplace while treatment success levels will vary.
-
![Cells-cancer-cells-iStock-1139782423]( "Identifying & Understanding Differentiators In CAR T-Cell Therapy")
Hematologist Dr. Robert S. Negrin takes a deep dive into identifying and understanding the central differentiators in cell therapy clinical trials.
-
![iStock-1192540193-puzzle-team-solve]( "It Takes Two – The Importance Of Study Partners In Alzheimer’s Disease Clinical Trials")
Alzheimer’s Disease currently afflicts close to 50 million people worldwide, highlighting the importance of clinical trials for this condition. Alzheimer’s studies are unique in that they require an additional participant to assess the patient’s mental and physical health during the trial. But what are the characteristics of a viable study partner?
-
![oncology PS]( "What Sets Oncology Clinical Studies Apart From Other Trials? Four Top Differentiators")
Oncology trials may start out similarly to other therapeutic indications, but they differ radically in relation to early phases of the study, biomarkers, drug characteristics, and competition for patients. In this article, Dr. Alex Adjei speaks about the top four differentiators in oncology studies that make them unique among other trials.
NEWS
-
Biorasi Joins Nova Southeastern University To Spur Healthcare Job Growth In South Florida9/8/2018
Biorasi, a leading full-service global contract research organization (CRO), is excited to announce two new certificate programs through Nova Southeastern University to provide targeted education and job skills for future healthcare workers in South Florida. The certificate programs are a joint effort between the two organizations to create a Clinical Research Associate (CRA) graduate certificate program through the university’s Dr. Pallavi Patel College of Health Care Sciences. This certificate program will help prepare students to enter the rapidly growing field of clinical research and provide them with the practical skills and knowledge to secure employment in a well-paying career in the sciences.